Whole slide | Tissuepathology.com

Aiforia closes a deal with a private diagnostic laboratory in Italy

Erica Goodpaster — Thu, 23 Apr 2026 12:22:10 +0000

Using Aiforia Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed an agreement with Laboratorio di Analisi La Fontana, a private diagnostic laboratory in Italy, to collaborate in AI-powered digital pathology. […]

The post Aiforia closes a deal with a private diagnostic laboratory in Italy first appeared on Tissuepathology.com.

Pictor Labs Introduces On-Prem Deployment for Virtual Stains at USCAP 2026

Erica Goodpaster — Mon, 06 Apr 2026 13:05:44 +0000

Pictor Labs: AI-Powered Virtual Staining Can Now Run Directly Within Pathology Labs First-to-market, production-ready On-Prem deployment system enables secure, high-speed virtual staining without transmitting data to external cloud infrastructure Visit Pictor Labs at Booth #749 for a hands-on demonstration LOS ANGELES, March 23, 2026 /PRNewswire/ — Pictor Labs, the virtual staining company, enabling digital pathology adoption worldwide, today […]

The post Pictor Labs Introduces On-Prem Deployment for Virtual Stains at USCAP 2026 first appeared on Tissuepathology.com.

Ataraxis AI Launches Ataraxis Breast CTX, the First Predictive AI Test Estimating Individualized Chemotherapy Benefit in Breast Cancer

Erica Goodpaster — Tue, 31 Mar 2026 13:37:57 +0000

NEW YORK–(BUSINESS WIRE)–Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients. Ataraxis Breast combines digitized H&E pathology slides with clinical data to generate prognostic and […]

The post Ataraxis AI Launches Ataraxis Breast CTX, the First Predictive AI Test Estimating Individualized Chemotherapy Benefit in Breast Cancer first appeared on Tissuepathology.com.

Tempus Announces the Launch of Paige Predict

Erica Goodpaster — Wed, 21 Jan 2026 14:46:17 +0000

Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital pathology CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of Paige Predict, a suite of cutting-edge digital pathology applications that analyze hematoxylin and eosin […]

The post Tempus Announces the Launch of Paige Predict first appeared on Tissuepathology.com.

INFINITT North America Expands Digital Pathology Portfolio with FDA-Cleared Hamamatsu S360MD Scanner Integration

Erica Goodpaster — Fri, 19 Dec 2025 13:58:00 +0000

INFINITT North America, a leader in advanced healthcare imaging solutions, is excited to announce the newest addition to its digital pathology platform: the FDA-cleared Hamamatsu NanoZoomer S360MD Slide Scanner, now seamlessly integrated with the INFINITT Digital Pathology Solution (DPS). This milestone solidifies INFINITT’s position among the digital pathology sector’s top innovators and signals a new […]

The post INFINITT North America Expands Digital Pathology Portfolio with FDA-Cleared Hamamatsu S360MD Scanner Integration first appeared on Tissuepathology.com.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems

Erica Goodpaster — Fri, 05 Dec 2025 14:47:13 +0000

Indica Labs’ HALO AP Dx digital pathology platform for primary diagnostics has received FDA 510(k) clearance with Leica Biosystems’ Aperio GT 450 DX Scanner and is cleared for use with both SVS and DICOM file formats. ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica […]

The post Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems first appeared on Tissuepathology.com.